1. Home
  2. DRTS vs ALVO Comparison

DRTS vs ALVO Comparison

Compare DRTS & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$9.73

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.92

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
ALVO
Founded
2015
2013
Country
Israel
Luxembourg
Employees
121
1460
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
978.2M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRTS
ALVO
Price
$9.73
$3.92
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$8.67
$8.00
AVG Volume (30 Days)
933.1K
1.0M
Earning Date
05-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
$699.98
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$2.94
52 Week High
$11.62
$9.94

Technical Indicators

Market Signals
Indicator
DRTS
ALVO
Relative Strength Index (RSI) 52.32 55.06
Support Level $6.59 $3.09
Resistance Level $11.48 $4.17
Average True Range (ATR) 0.83 0.32
MACD -0.09 0.03
Stochastic Oscillator 39.92 59.39

Price Performance

Historical Comparison
DRTS
ALVO

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: